GxP technology expertise for venture capital firms and incubators

USDM helps pre-commercial companies accelerate their journey to commercialization

Startups can save time with rapid deployment of enterprise wide GxP applications

Learn how USDM enabled compliance for multiple IT systems in half the time so a startup biotech customer could meet its FDA submission deadline.

With complex regulations in place, emerging companies can be challenged by lengthy validation workflows.

Our team knows you may feel concerns when monitoring your newest life science start-up go through the R&D to commercialization process.

Having an optimized IT strategy and roadmap in place can communicate and eliminate challenging hurdles. With our unmatched expertise in the life sciences industry, we can be your go-to trusted advisor in this process

We have established strong partnerships with leading technology vendors.

Ensure greater operational oversight of your investments with USDM.

Through our ongoing services for life science companies, we can be of great value to your firm. We work in collaboration with emerging companies, assisting them in establishing and implementing their IT strategy and roadmap.

Our interim CIO services accelerate digital transformation as we select the right technology vendors to ensure a continuous state of compliance.

Our GxP solutions minimize risk and control costs.

Our approach examines people, technology, and global regulations to harmonize and accelerate commercialization while ensuring continuous compliance.

Working with USDM, our team of experts will provide ongoing guidance and education for early-stage life science startups.

Focus on product innovation, we'll manage the validation workload.

250+ Emerging Clients

20+ Years of Experience